Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 258.81%250.88M | -6.41%56.58M | -6.41%56.58M | 24.36%68.67M | 70.31%92.22M | 63.09%69.92M | 98.15%60.45M | 98.15%60.45M | -19.56%55.22M | 37.82%54.15M |
-Cash and cash equivalents | 400.64%146.48M | 31.54%29.67M | 31.54%29.67M | 32.67%26.16M | -23.76%28.79M | 24.65%29.26M | 40.15%22.56M | 40.15%22.56M | -49.45%19.72M | 155.79%37.77M |
-Restricted cash and investments | 156.75%104.4M | -29.00%26.9M | -29.00%26.9M | 19.74%42.51M | 287.19%63.43M | 109.60%40.66M | 162.91%37.89M | 162.91%37.89M | 19.77%35.5M | -33.21%16.38M |
Receivables | -24.14%25.8M | 71.33%57.84M | 71.33%57.84M | -5.55%31.68M | 60.98%42.02M | 2.79%34.01M | 32.13%33.76M | 32.13%33.76M | 14.82%33.54M | -76.59%26.1M |
Prepaid assets | 79.09%11.2M | 12.08%6.17M | 12.08%6.17M | -6.33%7.04M | 7.00%6.34M | 6.18%6.25M | -4.49%5.5M | -4.49%5.5M | 105.27%7.52M | 221.82%5.93M |
Derivative assets | --306K | 89.14%1.86M | 89.14%1.86M | ---- | ---- | ---- | --985K | --985K | ---- | ---- |
Total assets | 33.71%2.53B | -0.85%1.93B | -0.85%1.93B | -7.15%1.82B | -5.85%1.87B | -7.80%1.9B | -4.85%1.94B | -4.85%1.94B | -4.74%1.96B | -3.10%1.98B |
Liabilities | ||||||||||
Payables | 37.37%65.78M | 1.99%47.91M | 1.99%47.91M | 26.18%56.62M | 7.22%46.81M | 11.22%47.89M | 7.06%46.97M | 7.06%46.97M | -18.25%44.87M | 18.39%43.66M |
-Accounts payable | 58.71%51.39M | 13.59%35.11M | 13.59%35.11M | 48.68%44.1M | 15.14%33.87M | 11.25%32.38M | 4.85%30.91M | 4.85%30.91M | -25.36%29.66M | 20.76%29.42M |
-Other payable | -7.20%14.39M | -20.33%12.79M | -20.33%12.79M | -17.68%12.52M | -9.14%12.94M | 11.16%15.51M | 11.58%16.06M | 11.58%16.06M | 0.37%15.21M | 13.77%14.24M |
Long term debt and capital lease obligation | 34.27%1.25B | -1.18%967.65M | -1.18%967.65M | -15.53%847.44M | -12.62%906.33M | -14.88%930.15M | -9.10%979.2M | -9.10%979.2M | -5.40%1B | -3.96%1.04B |
Derivative product liabilities | 5,065.71%1.81M | -82.23%175K | -82.23%175K | --1.07M | ---246K | --35K | --985K | --985K | ---- | ---- |
Total liabilities | 35.08%1.32B | -0.87%1.02B | -0.87%1.02B | -13.33%910.32M | -11.74%955.81M | -13.98%978.25M | -8.41%1.03B | -8.41%1.03B | -6.09%1.05B | -3.26%1.08B |
Shareholders'equity | ||||||||||
Share capital | -98.56%729K | 0.00%50.51M | 0.00%50.51M | 0.00%50.51M | 0.00%50.51M | 0.00%50.51M | -0.01%50.51M | -0.01%50.51M | -0.02%50.51M | -0.03%50.51M |
-common stock | 43.50%729K | 0.20%509K | 0.20%509K | 0.00%508K | 0.00%508K | 0.00%508K | -0.59%508K | -0.59%508K | -1.74%508K | -2.50%508K |
-Preferred stock | --0 | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M |
Paid-in capital | 35.97%1.38B | -0.14%1.01B | -0.14%1.01B | -0.15%1.02B | -0.25%1.02B | -0.25%1.02B | -0.64%1.02B | -0.64%1.02B | -1.27%1.02B | -1.95%1.02B |
Retained earnings | -13.50%-167.68M | -4.11%-157.98M | -4.11%-157.98M | 1.08%-158.93M | 8.18%-153.74M | 0.79%-147.74M | 1.26%-151.74M | 1.26%-151.74M | -11.14%-160.67M | -4.08%-167.43M |
Other equity interest | 0.00%-1.63M | 0.00%-1.63M | 0.00%-1.63M | 0.00%-1.63M | 0.00%-1.63M | 0.00%-1.63M | 0.00%-1.63M | 0.00%-1.63M | 0.00%-1.63M | 0.00%-1.63M |
Total stockholders'equity | 32.24%1.21B | -0.83%905.2M | -0.83%905.2M | 0.02%906.6M | 1.24%910.82M | -0.15%916.82M | -0.50%912.81M | -0.50%912.81M | -3.12%906.44M | -2.89%899.68M |
Total equity | 32.24%1.21B | -0.83%905.2M | -0.83%905.2M | 0.02%906.6M | 1.24%910.82M | -0.15%916.82M | -0.50%912.81M | -0.50%912.81M | -3.12%906.44M | -2.89%899.68M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |